medigraphic.com

2014, Number 1

<< Back Next >>

Enf Infec Microbiol 2014; 34 (1)

Urine bacteriology in children with disabilities

López CG, Reyes GU, Gallegos VB, Reyes HD, Reyes HKL

Language: Spanish
References: 23
Page: 26-30
PDF size: 149.87 Kb.


ABSTRACT

Background. Escherichia coli is isolated from 59.7% to 72% of cases of urinary tract infections. In patients with disability, the employ of disposable diapers, and the difficulty to perform a correct genital hygiene are factors that contribute to increase the degree of periurethral contamination that predisposes to a higher rate of microbial colonization of the urinary tract.
Material and Methods. It was performed a prospective, observational, descriptive study in pediatric patients with disability treated as outpatient in pediatric surgery, pediatric urology or pediatrics, from January 1, 2010 to January 1, 2012. Statistical analysis was conducted with measures of central tendency, and frequencies.
Results. Most commonly isolated microbiological agents belonged to the Enterobacteriaceae family, mainly: Escherichia coli 209 (41.8%), Proteus 93 (18%), and Klebsiella 39 (7.8%).
conclusions. The percentage of colonization by Escherichia coli does not increase in the urinary tract of children with disabilities and it is equal to the population without disabilities.


REFERENCES

  1. Whiting P, Westwood M, Bojke L, Palmer S, Richardson G, Cooper J, et al. “Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model”. Health Technol Assess. 2006; 10: 1-154.

  2. Mohammad JH, Saffar MJ, Nemate I, Saffar H, Khalilian AR. “Increasing antibiotic resistence among uropatohegens isolated during years 2006-2009: Impact on the empirical management”. Int Braz J Urol. 2012; 38:25-32.

  3. Cavagnaro SMF. “Infección urinaria en la infancia”. Rev Chil Infect. 2005; 22: 161-168.

  4. Kjölvmark C, Akesson P, Linder A. “Elevated urine levels of heparin-binding protein in children with urinary tract infection”. Pediatr Nephrol. 2012; 13. DOI: 10.1007/ s00467-012-2132-x.

  5. Arredondo GJL, Segura CE, Calderón JE, Mancilla RJ, Sánchez HG, Solorzano SF. “Consenso Mexicano de infecciones de vías urinarias en pediatría”. Acta Pediat Mex 2007; 28: 289-293.

  6. Spahiu L. Hasbahta V. “Most frequent causes of urinary tract infections in children”. Med Arch. 2010; 64:88-90.

  7. Kaye D. “Infección de vías urinarias”. Clínicas Médicas de Norteamérica. 1991; 2:257-278.

  8. Wiles TJ, Kulesus RR, Mulvey MA. “Origins an virulence mechanisms of uropathogenic Escherichia coli”. Exp Mol Pathol. 2008; 85:11-19.

  9. Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U. “Molecular basis of commensalism in the urinary tract low virulence attenuation?” Infect Immun. 2008;76:695-703.

  10. Lloyd AL, Rasko DA, Mobley HLT. “Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli”. J Bacteriol. 2007;189:3532-3546.

  11. Rendon MA, Saldaña Z, Erdem AL, Montero NV, Vasquez A, Kaper JB, Puente JL, Giron JA. “Commensal and pathogenic Escherichi coli use a pilus adherence factor for epitelial cell colonization”. PNAS, 2007;104:10637- 10642.

  12. Cano V, Moranta D, Lobet-Brossa E, Bengoechea JA, Garmednia J. “Klebsiella pneumoniae triggers a cytotoxic effect on airway epitelial cells. BCM Microbiology 2009, 9(156) doi: 10.1186/1471-2180-9-156.

  13. Sekowska A. Pluta J, Buzała K, Gospodarek E. Susceptibility of klebsiella pneumonia isolated from urinary tract infections to quinolones. Article in Polish”. Med Disw Mikrobiol. 2011;63:53-57

  14. Lee JC, Lee EJ, Lee JH, Jun SH, Choi CW, Kim SI, Kang SS, Hyun S. “Klebsiella pneumonia secretes outers membrane vesicles that induce the innate immune response”. FEMS Microbiol Lett. 2012;19. Doi:10.1111/j.1574- 6968.2012.02549.x.

  15. López CG, Reyes GU, Hernández CP. “Proteína de Tamm-Horsfall: Implicaciones clínicas en la vía urinaria”. Bol Clin Hosp Infant Edo Son 2010;27:125-128.

  16. Galicia JMM, Sandoval CC, Rojas HR, Magaña SH. “Quimiotaxis bacteriana y flavonoides: Perspectivas para el uso de probióticos”. Tropical and Subtropical Agroecosystems. 2011; 14:891-900.

  17. López CG, Sosa VJ, Paulo AF, Morales-García J. “Reflujo vesico-vaginal asociado a vulvoganitis crónica en pediatría”. Bol Clin Hosp Infant Son. 2010;27:16-21.

  18. Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O´Kelly F, Flynn RJ, McDermott, Murphy P, Grainger R, Fennell JP, Thornhill JA. “The changing pattern of antimicrobial resistance within 42 033 Escherichia coli isolates from nosocomial, comunity and urology patient-specific urinary tract infections, Dublin, 1999-2009”. BJU Int 2011: 10.1111/j.1464-410X2011.105228.x.

  19. Nakamura T, Komatsu M, Yamasaki K et al. “Epidemiology of Escherichia coli, Klebsiella Species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki region of Japan”. AJCP, 2012, 137:620-626

  20. Navidinia M, Karimi A, Rahbar M, et al. “Study prevalence of verotoxigenic E. coli isolated from urinay tract infections (UTIs) in an Iranian Children Hospital”. Open Microbiol J 2012:6:1-4.

  21. Jacobsen SM, Shirtliff ME. “Proteus mirabilis bioflims and catheter-associated urinary tract infections”. Virulence. 2011;2: 460-465.

  22. Anyanwu LJ, Kashibu E, Edwin CP, Mohammad AM. “Microbiology of smegma in boys in Kano, Nigeria”. J Surg Res. 2012; 173:21-25.

  23. Reyes GU, Reyes HU, Reyes HD, López CG, Castell RE, Reyes HK, Cruz GL, Vásquez LI. “Sensibilidad Antimicrobiana de E. coli en niños con Infección de Vías Urinarias en una Clínica Privada. Primer Período 2010”. Bol Clin Hosp Infant Edo Son 2012; 29(1): 24-28.




2020     |     www.medigraphic.com